利用低成本电生物传感器芯片对人造泪膜中的乳铁蛋白和β -2微球蛋白进行无标记检测

Muhammad S. Khan, K. Dighe, Zhen Wang, E. Daza, A. Schwartz-Duval, Conor P. Rowley, Isaac A. Calvillo, Dr. Santoshi Misra, Leanne T. Labriola, D. Pan
{"title":"利用低成本电生物传感器芯片对人造泪膜中的乳铁蛋白和β -2微球蛋白进行无标记检测","authors":"Muhammad S. Khan, K. Dighe, Zhen Wang, E. Daza, A. Schwartz-Duval, Conor P. Rowley, Isaac A. Calvillo, Dr. Santoshi Misra, Leanne T. Labriola, D. Pan","doi":"10.1109/HIC.2017.8227587","DOIUrl":null,"url":null,"abstract":"In this paper, we present a biosensor chip to study two important biomarkers, lactoferrin (LCF) and beta-2-microglubin (B2M) present in our tear fluid. LCF and B2M have direct relevance with dry eye syndrome and diabetic retinopathy in patients respectively. We have developed a multi-layer paper-based biosensor chip connected with handheld printed circuit board (PCB) to monitor the effectiveness of B2M and LCF in contrived tear film (TF) with a wide range of detection (RoD) from 0.001 to 1ng/mL (R2=0.9886) and 1 to 10mg/mL (R2=0.9554) respectively. Multilayer biosensor is composed of graphene nanoplatelet and diblock-co-polymer coated on a filter paper followed by deposition of micro-Au electrodes. Anti-LCF and anti-B2M antibodies were immobilized via 3,3'-dithiodipropionic acid di(N-hydroxysuccinimide ester (DTSP) as a self-assembled monolayer (SAM) on Au. In addition to electrical measurements in real-time setup, Raman spectral analysis and SEM were utilized to characterize the sensor surface before and after testing the relevant proteins. We anticipate that the fabricated sensor chip has promising application to study dry-eye-disease (DED) and diabetes in Point-of-care (POC) setting.","PeriodicalId":120815,"journal":{"name":"2017 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT)","volume":"117 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2017-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Label-free detection of lactoferrin and beta-2-microglobuin in contrived tear film using a low-cost electrical biosensor chip\",\"authors\":\"Muhammad S. Khan, K. Dighe, Zhen Wang, E. Daza, A. Schwartz-Duval, Conor P. Rowley, Isaac A. Calvillo, Dr. Santoshi Misra, Leanne T. Labriola, D. Pan\",\"doi\":\"10.1109/HIC.2017.8227587\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this paper, we present a biosensor chip to study two important biomarkers, lactoferrin (LCF) and beta-2-microglubin (B2M) present in our tear fluid. LCF and B2M have direct relevance with dry eye syndrome and diabetic retinopathy in patients respectively. We have developed a multi-layer paper-based biosensor chip connected with handheld printed circuit board (PCB) to monitor the effectiveness of B2M and LCF in contrived tear film (TF) with a wide range of detection (RoD) from 0.001 to 1ng/mL (R2=0.9886) and 1 to 10mg/mL (R2=0.9554) respectively. Multilayer biosensor is composed of graphene nanoplatelet and diblock-co-polymer coated on a filter paper followed by deposition of micro-Au electrodes. Anti-LCF and anti-B2M antibodies were immobilized via 3,3'-dithiodipropionic acid di(N-hydroxysuccinimide ester (DTSP) as a self-assembled monolayer (SAM) on Au. In addition to electrical measurements in real-time setup, Raman spectral analysis and SEM were utilized to characterize the sensor surface before and after testing the relevant proteins. We anticipate that the fabricated sensor chip has promising application to study dry-eye-disease (DED) and diabetes in Point-of-care (POC) setting.\",\"PeriodicalId\":120815,\"journal\":{\"name\":\"2017 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT)\",\"volume\":\"117 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-12-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2017 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/HIC.2017.8227587\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2017 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/HIC.2017.8227587","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

在本文中,我们提出了一个生物传感器芯片来研究两种重要的生物标志物,乳铁蛋白(LCF)和β -2-微葡糖蛋白(B2M)存在于泪液中。LCF和B2M分别与干眼综合征和糖尿病视网膜病变有直接关系。我们开发了一种与手持式印刷电路板(PCB)连接的多层纸质生物传感器芯片,用于监测人工泪膜(TF)中B2M和LCF的有效性,其检测范围(RoD)分别为0.001至1ng/mL (R2=0.9886)和1至10mg/mL (R2=0.9554)。多层生物传感器由涂覆在滤纸上的石墨烯纳米板和二嵌段共聚物组成,然后沉积微金电极。将抗lcf和抗b2m抗体通过3,3'-二硫代二丙酸二(n -羟基琥珀酰亚胺酯(DTSP)作为自组装单层(SAM)固定在Au上。除了实时设置中的电测量外,还利用拉曼光谱分析和扫描电镜对传感器表面进行了表征,并在测试相关蛋白质前后进行了表征。我们预计该传感器芯片在干眼病(DED)和糖尿病的即时护理(POC)研究中具有广阔的应用前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Label-free detection of lactoferrin and beta-2-microglobuin in contrived tear film using a low-cost electrical biosensor chip
In this paper, we present a biosensor chip to study two important biomarkers, lactoferrin (LCF) and beta-2-microglubin (B2M) present in our tear fluid. LCF and B2M have direct relevance with dry eye syndrome and diabetic retinopathy in patients respectively. We have developed a multi-layer paper-based biosensor chip connected with handheld printed circuit board (PCB) to monitor the effectiveness of B2M and LCF in contrived tear film (TF) with a wide range of detection (RoD) from 0.001 to 1ng/mL (R2=0.9886) and 1 to 10mg/mL (R2=0.9554) respectively. Multilayer biosensor is composed of graphene nanoplatelet and diblock-co-polymer coated on a filter paper followed by deposition of micro-Au electrodes. Anti-LCF and anti-B2M antibodies were immobilized via 3,3'-dithiodipropionic acid di(N-hydroxysuccinimide ester (DTSP) as a self-assembled monolayer (SAM) on Au. In addition to electrical measurements in real-time setup, Raman spectral analysis and SEM were utilized to characterize the sensor surface before and after testing the relevant proteins. We anticipate that the fabricated sensor chip has promising application to study dry-eye-disease (DED) and diabetes in Point-of-care (POC) setting.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信